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Abstract
Objective: To estimate the prevalence of undiagnosed HIV, the prevalence of diagnosed HIV, and proportion of HIV that is
undiagnosed in populations with similar demographics as the Universal Screening for HIV in the Emergency Room (USHER)
Trial and the Brigham and Women’s Hospital (BWH) Emergency Department (ED) in Boston, MA. We also sought to estimate
these quantities within demographic and risk behavior subgroups.
Method: We used data from the USHER Trial, which was a randomized clinical trial of HIV screening conducted in the BWH
ED. Since eligible participants were HIV-free at time of enrollment, we were able to calculate the prevalence of undiagnosed
HIV. We used data from the Massachusetts Department of Public Health (MA/DPH) to estimate the prevalence of diagnosed
HIV since the MA/DPH records the number of persons within MA who are HIV-positive. We calculated the proportion of HIV
that is undiagnosed using these estimates of the prevalence of undiagnosed and diagnosed HIV. Estimates were stratified
by age, sex, race/ethnicity, history of testing, and risk behaviors.
Results: The overall expected prevalence of diagnosed HIV in a population similar to those presenting to the BWH ED was
0.71% (95% CI: 0.63%, 0.78%). The prevalence of undiagnosed HIV was estimated at 0.22% (95% CI: 0.10%, 0.42%) and
resultant overall prevalence was 0.93%. The proportion of HIV-infection that is undiagnosed in this ED-based setting was
estimated to be 23.7% (95% CI: 11.6%, 34.9%) of total HIV-infections.
Conclusions: Despite different methodology, our estimate of the proportion of HIV that is undiagnosed in an ED-setting
was similar to previous estimates based on national surveillance data. Universal routine testing programs in EDs should use
these data to help plan their yield of HIV detection.
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Introduction
Among academic Emergency Departments (EDs) surveyed
between December 2006 and March 2007, 13% (13/102) had
instituted routine HIV screening policies in response to the 2006
Centers for Disease Control and Prevention (CDC) revised
guidelines [1,2]. The number of new cases identified by such
routine testing programs depends greatly on the prevalence of
undiagnosed HIV in these settings. The estimated proportion of
HIV infection that remains undiagnosed in the United States
decreased from 25% in 2000 [3] to 21% in 2006 [4] and to 20% in
2008 [5]. One possible explanation for this downward trend could
be attributed to wide implementation of universal screening
efforts. As universal HIV screening becomes more frequently
implemented and the prevalence of undiagnosed HIV becomes
less common, the proportion of HIV that is undiagnosed
decreases. Older ED studies (1987–1990) throughout the nation
have reported much higher estimates for the percentage of HIV
that is undiagnosed, ranging from 49%–77% [6–10]. Studies from
the mid-1990 s reported estimates of the percentage of HIV that is
undiagnosed to be in line with more current CDC estimates in the
US (range 20–28%) [11–13]. The most recent study, which was
conducted by Clauss and colleagues in 2007, estimated that the
proportion of HIV that was undiagnosed was 28.9% [14].
An accurate estimate of the current prevalence of undiagnosed
HIV is critical to projecting the value of HIV screening programs.
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estimates so that other investigators may apply these methods to
their setting. This paper aims to report the overall prevalence of
undiagnosed HIV-infection within specific demographic groups in
the Brigham and Women’s Hospital (BWH) ED from 2007–2009,
during the Universal Screening for HIV in the Emergency Room
(USHER) Trial. Using these estimates of the prevalence of
undiagnosed HIV-infection, we also estimate the proportion of
HIV infection that is undiagnosed in patients similar to those in
the USHER study and the BWH ED with respect to age, race/
ethnicity, sex, and risk behaviors.
Methods
Ethics statement
The Brigham and Women’s Hospital institutional review board
approved the study. Written informed consent was obtained from
all participants in the USHER Trial.
Data sources and elements
This analysis was conducted within the context of the USHER
Trial. To be eligible for participation in the USHER Trial, ED
patients had to be: 1) between the ages of 18 and 75; 2) English- or
Spanish-speaking; and 3) not known to be HIV-infected. Patients
with an emergency severity index (ESI) score of 1 or 2 (on a scale
of 1 to 5, with 1 being most severe) needed written authorization
from the attending ED physician to be considered eligible [15–17].
A complete set of inclusion and exclusion criteria for USHER
Trial are presented elsewhere [18]. In addition to data from the
USHER Trial, we used data from the BWH ED, the
Massachusetts Department of Public Health (MA/DPH) surveil-
lance program [19], and the US Census Bureau [20].
USHER Trial data. Demographic data (age, race/ethnicity,
and sex) were collected at the time of enrollment. For the purposes
of this analysis, we dichotomized age as those less than 45 years
and those 45 years or older. We chose 45 years because it
corresponded to the median age among newly identified cases of
HIV-infection in the USHER Trial. We categorized race/
ethnicity into four groups; 1) non-Hispanic white, 2) non-
Hispanic black, 3) Hispanic, and 4) other. Enrolled participants
were also asked to complete an 86-item survey. Details of the
survey have been published elsewhere [21]. From this survey, we
used data on self-reported history of testing and risk behaviors.
History of testing was categorized into four groups; 1) previously
tested/no date reported, 2) previously tested/within the last 5
years, 3) previously tested/5 or more years ago, 4) missing history
of testing information. We chose a five year threshold because we
hypothesized that the participants’ ability to recall with any
accuracy beyond five years was limited and that there have been
secular changes in HIV testing over the past five years.
Participants were classified as having a sexual risk behavior if
they reported one of the following: 1) greater than one sexual
partner during the last 12 months, 2) reported condom use as less
than always, or 3) self-report of having sexual contact with
partners who are known to have HIV, have been incarcerated, or
who use injectable illicit drugs. Alcohol risk behavior was assessed
using the 10-item Alcohol Use Disorders Identification Test
(AUDIT) [22]. A score of 8 or higher was used to classify those as
having the alcohol risk behavior. Data on use of 10 illicit drugs
(heroin, cocaine/crack, speed, oxycontin/other narcotics, poppers,
marijuana, crystal methamphetamine, LSD, ecstasy, and other)
were collected. Participants were classified as having the illicit drug
use risk behavior if they reported having used one of the drugs at
least occasionally or two of the drugs once. We analyzed the
missing data patterns by calculating the proportion missing for
those variables among those that were and were not tested in the
USHER Trial. If the distributions of missing values were similar
for those who were and were not tested then we can consider the
data to be missing at random (MAR). Data that are MAR yield
point estimates that are not biased when using standard statistical
methodology. However, precision may be affected due to the
decrease in sample size [23].
BWH ED data. We obtained demographic data (age, race/
ethnicity, and sex) for all patients who visited the ED between
January 1, 2008 and May 31, 2009. Age and race data were
categorized similarly to that of the USHER Trial demographic
data.
MA/DPH HIV Surveillance data. The number of people
living with HIV or AIDS in 2008 was obtained from the MA/
DPH surveillance program. The MA/DPH surveillance program
classified the number of cases of HIV-infection by age (18–24, 25–
34, 35–44, 45–54, 55–64, and 65+), sex, and race/ethnicity (non-
Hispanic white, non-Hispanic black, Hispanic, and other).
US Census Bureau data. The number of people residing in
MA in 2008 stratified by the same age, sex, and race/ethnicity
groups provided by the MA/DPH surveillance program was
obtained from published estimates from the US Census Bureau
[20].
Data Analysis
Estimation of the prevalence of undiagnosed HIV-
infection. The prevalence of undiagnosed HIV-infection was
calculated as the number of new HIV diagnoses in the USHER
Trial divided by the number of trial participants tested. This
quantity is an estimate of the prevalence of undiagnosed HIV
because those who self-reported prior HIV diagnoses were not
eligible for enrollment in the USHER Trial. We estimated the
overall prevalence of undiagnosed HIV-infection and for specific
demographic and risk subgroups in the USHER Trial. Clopper-
Pearson 95% confidence intervals, which is an exact interval based
on the binomial distribution, were constructed for all estimates
[24].
Estimation of the expected prevalence of diagnosed HIV-
infection. We estimated the expected prevalence of diagnosed
HIV-infection for the BWH ED by multiplying the mean
prevalence for each subgroup in the MA/DPH surveillance
program by the proportion per subgroup among all patients
presenting to the BWH ED. This step-by-step process was carried
out as follows:
1. The prevalence of diagnosed HIV-infection was calculated by
age, sex, and race/ethnicity for the state of MA. To do so, the
number of people known to be living with a diagnosis of HIV/
AIDS from the MA/DPH surveillance program was divided by
the number of people residing in MA from published estimates
from the US Census Bureau (data not shown) [20].
2. We calculated weights for each age, sex, and race/ethnicity
combination in the BWH ED by dividing the number of
patients in each stratum by the total number of patients
presenting to the BWH ED.
3. Lastly, the age, sex, and race/ethnicity specific prevalences in
MA were multiplied by corresponding weights in the BWH ED
and then summed to obtain the expected weighted prevalence
of diagnosed HIV-infection in the BWH ED.
To estimate the prevalence of diagnosed HIV-infection for each
level of a variable, the weights had to sum to one. For example, the
estimated prevalence of diagnosed HIV among those 18–44 years
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represented 9.7% of the overall population in the BWH ED. These
two quantitiesweremultiplied togetherand theprocesswasrepeated
for all age, sex, and race/ethnicity groupings. The sum of these
values serves as an estimated overall expected prevalence of
diagnosed HIV in a population similar to the BWH ED. To
estimate the prevalence of diagnosed HIV-infection for those ages
18–44, the weights were calculated among those 18–44 as the
number of patients within each combination of sex and race/
ethnicity divided by the total number of people ages 18–44. These
weights were then multiplied by the corresponding prevalence of
HIV among those 18–44 within each sex and race/ethnicity
combination and summed to obtain the weighted prevalenceof HIV
for those ages 18–44. The calculation was similar for the expected
prevalence of diagnosed HIV-infection by race/ethnicity and sex.
We also calculated the prevalence of diagnosed HIV-infection
by history of testing and risk behaviors. To do this, we used the
method above within each subgroup for history of testing and risk
behavior. For example we used the distribution of age, race/
ethnicity, and sex in the USHER Trial among those who were
previously tested in the last five years as the weights for estimating
the expected prevalence of diagnosed HIV-infection among those
had been previously tested in the previous five years. The sampling
distribution of the expected prevalence of diagnosed HIV-infection
is not known because it is a weighted prevalence. Thus, we used
simulations to construct empirical 95% confidence intervals for all
estimates (see Supporting Information Appendix S1) [25].
Estimation of percentage of HIV that is undiagnosed. The
percentage of HIV that is undiagnosed for persons similar to those
presenting to the BWH ED was calculated by dividing the prevalence
of undiagnosed HIV-infection by the sum of the prevalence of
undiagnosed HIV-infection and the estimated prevalence of
diagnosed HIV-infection. The formula is shown below where pu
represents the prevalence of undiagnosed HIV-infection and pd
represents the prevalence of diagnosed HIV-infection.
% of HIV that is undiagnosed~
pu
puzpd
Similar to the expected prevalence of diagnosed HIV-infection, the
percentage of HIV that is undiagnosed does not follow a known
distribution. Thus, empirical 95% confidence intervals were
constructed for all estimates (see Supporting Information Appendix
S1 for technical detail regarding construction of empirical 95%
confidence interval) [25].
Estimation of the ratio of undiagnosed HIV to diagnosed
HIV. Lastly, we also estimated the ratio of undiagnosed HIV to
diagnosedHIV.Thiswasdone bydividingtheestimatedprevalence
ofundiagnosed HIVbytheestimated prevalenceofdiagnosedHIV.
This metric will be useful in situations when only the prevalence of
diagnosed HIV is known as the prevalence of undiagnosed HIV can
be estimated by simply multiplying this ratio by the known
prevalence of diagnosed HIV infection in a particular setting.
Results
Demographics of USHER Trial participants who were
tested for HIV
A total of 4,056 participants were HIV tested in the USHER
Trial. Of these, 2,954 (75%) were between the ages of 18–44;
2,604 (65%) were female; 1,190 (29%) were non-Hispanic white;
915 (23%) were non-Hispanic black; 1,461 (36%) were Hispanic,
and 490 (12%) were other (Table 1). The distribution of the history
of testing and HIV risk behaviors are also shown in Table 1.
Missing data patterns of history of testing and risk
behaviors
We compared the proportion of missing data for certain
parameters of interest between those tested in the USHER Trial
and those not tested. We found that the proportion missing data
for history of testing was similar for those tested in the USHER
Trial (36%) compared to those who were not tested in the USHER
Trial (39%). The proportion of missing data for the risk behaviors
was slightly higher among those who were not tested in the
USHER Trial. For the alcohol risk behavior, 48% of those not
tested were missing compared to 41% of those tested in the
USHER Trial. For the drug risk behavior, 50% of those not tested
were missing compared to 43% of those who were tested in the
USHER Trial. Lastly, for the sexual risk behavior, 44% of those
not tested were missing compared to 38% of those who were tested
in the USHER Trial.
Prevalence of undiagnosed HIV in the USHER Trial
The USHER Trial identified 9 new cases of HIV-infection for
an undiagnosed prevalence of 0.22% (95% CI: 0.10%, 0.42%).
The prevalence of undiagnosed HIV was 0.51% (95%CI: 0.16%,
1.18%) in those age 45–75 years compared to 0.14% (95% CI:
0.04%, 0.35%) in those 18–44 years of age. The prevalence of
undiagnosed HIV ranged from 0.04% (95% CI: 0.00%, 0.21%) in
females to 0.56% (95% CI: 0.24%, 1.10%) in males. The
prevalence of undiagnosed HIV was similar across race/ethnicity
groups. Those who were previously tested in the last 5 years had
an estimated prevalence of undiagnosed HIV of 0.10% (95% CI:
0.00%, 0.54%) compared to 0.34% (95% CI: 0.09%, 0.87%) for
those who were previously tested five or more years ago or never
tested. Estimates of the prevalence of undiagnosed HIV within the
trial are shown in Table 1 for all subgroups.
Estimated percentage of HIV that is undiagnosed based
on BWH ED demographics
The overall expected prevalence of diagnosed HIV in a
population similar to those presenting to the BWH ED was
estimated to be 0.71% (95% CI: 0.63%, 0.78%). This estimate of
anticipated diagnosed HIV infection combined with the estimate
of the prevalence of undiagnosed HIV (0.22%) yielded an overall
prevalence of 0.93%.To obtain the proportion of HIV that is
undiagnosed based on trial demographics, the prevalence of
undiagnosed HIV (0.22%) was divided by the overall prevalence
(0.93%); a projected 23.7% (95% CI: 11.6%, 34.9%) of all HIV
infections were undiagnosed. The proportion of HIV-infection
that was undiagnosed was estimated for demographic subgroups
(Table 2). Among those 18–44 years old, 19.4% (95% CI: 5.1%,
33.8%) of HIV infection is estimated to be undiagnosed compared
to 37.0% (95% CI: 10.3%, 54.2%) among those 45–75 years old.
The estimated proportion of HIV that was undiagnosed was
37.1% (95% CI: 18.0%, 51.0%) for males and 6.8% (95% CI:
0.0%, 19.3%) for females. Those of other race had the highest
estimated proportion of undiagnosed HIV (80.4%; 95% CI: 0.0%,
98.4%). The proportion of HIV that was undiagnosed among
non-Hispanic whites, non-Hispanic blacks, and Hispanics was
48.6% (95% CI: 0.0%, 72.4%), 11.2% (95% CI: 0.0%, 23.6%),
and 16.0% (95% CI: 0.0%, 30.6%), respectively.
Estimated percentage of HIV that is undiagnosed by
history of testing and risk behavior
The proportion of undiagnosed HIV-infection for those who
previously tested in the last 5 years was 11.9% (95% CI: 0.0%,
40.0%), while it was 35.8% (95% CI: 8.3%, 66.7%) who were
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HIV that was undiagnosed among those reporting sexual risk
behavior was 20.5% (95% CI: 3.8%, 42.1%), compared to 0.0%
(95% CI: 0.0%, 100.0%) among those not reporting a sexual risk
behavior. Those reporting an illicit drug risk behavior had
proportion of HIV that was undiagnosed estimated at 31.5%
(95% CI: 0.0%, 66.7%) compared to 10.1% (95% CI: 0.0%,
33.3%) in those who not report using illicit drugs. The proportion
of HIV that is undiagnosed was similar by alcohol risk behavior
group (Table 3).
Estimation of the ratio of undiagnosed HIV to diagnosed
HIV. The ratio of undiagnosed HIV to diagnosed HIV in a
population with demographic features similar to the BWH ED was
0.31. Estimates varied in a similar fashion as the estimated
percentage of HIV that is undiagnosed. Estimates for the ratio of
undiagnosed HIV to diagnosed HIV are shown in Tables 2 and 3.
Discussion
We estimated the proportion of HIV-infection that is undiag-
nosed in the ED setting based on data from the USHER Trial and
Table 1. Prevalence of undiagnosed HIV in the USHER Trial for the overall sample and by demographic and risk factors.
Number tested (%) Number HIV positive
Prevalence of undiagnosed HIV
(95% CI)
Overall 4,056 9 0.22% (0.10, 0.42)
Age
18–44 years old 2,954 (75%) 4 0.14% (0.04, 0.35)
45–75 years old 987 (25%) 5 0.51% (0.16, 1.18)
Sex
Male 1,428 (35%) 8 0.56% (0.24, 1.10)
Female 2,604 (65%) 1 0.04% (0.00, 0.21)
Age and Sex
18–44 years old
Male 1,010 (26%) 4 0.40% (0.11, 1.01)
Female 1,929 (49%) 0 0.00% (0.00, 0.19)
45–75 years old
Male 377 (10%) 4 1.06% (0.29, 2.69)
Female 603 (15%) 1 0.17% (0.00, 0.92)
Race/ethnicity
Non-Hispanic White 1,190 (29%) 2 0.17% (0.02, 0.61)
Non-Hispanic Black 915 (23%) 2 0.22% (0.03, 0.79)
Hispanic 1,461 (36%) 3 0.21% (0.04, 0.60)
Other 490 (12%) 2 0.41% (0.05, 1.47)
History of Testing
Previously tested/no date 376 (9%) 1 0.27% (0.01, 1.47)
Previously tested/,5 years 1,034 (25%) 1 0.10% (0.00, 0.54)
Previously tested/5+years or never tested 1,172 (29%) 4 0.34% (0.09, 0.87)
Missing history of testing information 1,474 (36%) 3 0.20% (0.04, 0.59)
Sexual Risk*
Yes 2,187 (54%) 4 0.18% (0.05, 0.47)
No 310 (8%) 0 0.00% (0.00, 1.18)
Missing 1,559 (38%) 5 0.32% (0.10, 0.75)
Alcohol risk**
Yes 365 (9%) 1 0.27% (0.01, 1.52)
No 1,941 (48%) 4 0.21% (0.06, 0.53)
Missing 1,750 (43%) 4 0.23% (0.06, 0.58)
Drug Risk***
Yes 1,024 (25%) 3 0.29% (0.06, 0.85)
No 1,293 (32%) 1 0.08% (0.00, 0.43)
Missing 1,739 (43%) 5 0.29% (0.09, 0.67)
*Participants who had missing data for three or more of the items related to sexual risk and not reporting risk behavior on other factors were classified as ‘missing’.
**A score of 8 or higher is considered as having the alcohol risk behavior. If answers were provided to fewer than 5 questions, the alcohol risk behavior was noted as
‘missing’.
***If answers to at least 3 drug-related questions were missing and no other drug-related behavior was reported, the drug behavior was marked ‘missing’.
doi:10.1371/journal.pone.0027701.t001
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and sex distributions in the BWH Emergency Department and prevalence of diagnosed HIV in the MA/DPH Surveillance Program.
N( % )
Prevalence of
diagnosed HIV
(95% CI)
Percentage of HIV
that is undiagnosed*
(95% CI)
Ratio of
undiagnosed to
diagnosed HIV
Overall 48,599 0.71% (0.63, 0.78) 23.7% (11.6, 34.9) 0.31
Age
18–44 years old 26,942 (55%) 0.58% (0.50, 0.68) 19.4% (5.1, 33.8) 0.24
45–75 years old 21,657 (45%) 0.87% (0.76, 1.00) 37.0% (10.3, 54.2) 0.59
Sex
Male 19,284 (40%) 0.95% (0.81, 1.09) 37.1% (18.0, 51.0) 0.59
Female 29,315 (60%) 0.55% (0.46, 0.63) 6.8% (0.0, 19.3) 0.07
Age and Sex
18–44 years old
Male 9,780 (20%) 0.65% (0.49, 0.81) 38.1% (11.6, 58.0) 0.62
Female 17,162 (35%) 0.54% (0.43, 0.66) 0.0% (0.0, 10.1) 0.00
45–75 years old
Male 9,504 (20%) 1.24% (1.02, 1.47) 46.1% (15.4, 63.9) 0.85
Female 12,153 (25%) 0.58% (0.44, 0.72) 22.7% (0.0, 48.7) 0.29
Race/ethnicity
Non-Hispanic White 24,373 (50%) 0.18% (0.13, 0.23) 48.6% (0.0, 72.4) 0.94
Non-Hispanic Black 10,973 (23%) 1.74% (1.49, 2.00) 11.2% (0.0, 23.6) 0.13
Hispanic 9,558 (20%) 1.10% (0.90, 1.31) 16.0% (0.0, 30.6) 0.19
Other 3,695 (8%) 0.10% (0.00, 0.22) 80.4% (0.0, 98.4) 4.10
*Percentage of HIV that is undiagnosed is calculated using the estimates of prevalence of undiagnosed HIV from Table 1.
doi:10.1371/journal.pone.0027701.t002
Table 3. The expected prevalence of diagnosed HIV and percentage of HIV that is undiagnosed based on HIV history of testing
and risk behavior in the USHER Trial and prevalence of diagnosed HIV in the MA/DPH Surveillance Program.
Prevalence of
diagnosed HIV
(95% CI)
Percentage of HIV
that is undiagnosed*
(95% CI)
Ratio of undiagnosed
to diagnosed HIV
History of Testing
Previously tested/no date 0.78% (0.00, 1.86) 25.7% (0.0, 100.0) 0.35
Previously tested/,5 years 0.74% (0.29, 1.35) 11.9% (0.0, 40.0) 0.14
Previously tested/5+years or never tested 0.61% (0.26, 1.11) 35.8% (8.3, 66.7) 0.56
Missing history of testing information 0.89% (0.41, 1.42) 18.3% (0.0, 41.2) 0.22
Sexual Risk
Yes 0.70% (0.37, 1.05) 20.5% (3.8, 42.1) 0.26
No 0.66% (0.00, 1.61) 0.0% (0.0, 100.0) 0.00
Missing 0.87% (0.38, 1.41) 26.9% (7.7, 50.0) 0.37
Alcohol risk
Yes 0.60% (0.00, 1.37) 31.0% (0.0, 100.0) 0.45
No 0.68% (0.36, 1.08) 23.6% (5.3, 45.0) 0.31
Missing 0.88% (0.46, 1.37) 20.7% (5.0, 41.7) 0.26
Drug Risk
Yes 0.63% (0.20, 1.17) 31.5% (0.0, 66.7) 0.46
No 0.71% (0.31, 1.24) 10.1% (0.0, 33.3) 0.11
Missing 0.88% (0.52, 1.32) 24.8% (6.3, 44.4) 0.33
*Percentage of HIV that is undiagnosed is calculated using the estimates of prevalence of undiagnosed HIV from Table 1.
doi:10.1371/journal.pone.0027701.t003
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proportion of HIV-infection that is undiagnosed to be 23.7%
(95% CI: 11.6%, 34.9%) when applying the BWH ED
demographic distribution. This value for the estimated proportion
of HIV-infection that is undiagnosed is difficult to determine and is
concordant with estimates from the CDC, though our method of
calculation differs from the CDC’s method [4,5]. The CDC
reports that 20% of all HIV is undiagnosed in the US as of 2008
[5]. Our findings are further supported by data from one Denver
ED where a blinded seroprevalence screening for HIV reported no
record of state-documented HIV infection for 20% of patients who
tested positive for the HIV antibody [12]. While the study by
Clauss et al. estimated the proportion of HIV that is undiagnosed
to be slightly higher at 28.9%, their estimate falls within the 95%
confidence interval of the overall estimate presented in this paper.
In this study, they conducted a blinded seroprevalence study while
linking demographic and clinical information to HIV status, which
allowed them to classify patients as having been diagnosed or not.
It is possible that previous diagnosis was misclassified if the patient
was diagnosed at a different institution. This may lead to a small
overestimation of the proportion of HIV that is undiagnosed in
that study. In contrast, our study calculated an estimate of the
prevalence of undiagnosed HIV-infection from a sample drawn
directly from the BWH ED and coupled it with an estimate of the
prevalence of diagnosed HIV-infection based on MA/DPH
surveillance data weighted by the demographic distribution in
the BWH ED [14].
In addition to the consistency of our results with others, despite
different methodology, our study is unique in that we were able to
calculate the proportion of undiagnosed HIV by specific
subgroups within the ED setting. We found that those 45 years
of age or older, men, non-Hispanic whites, and those who have
not recently been tested have a higher proportion of HIV-infection
that was undiagnosed among those with the disease. Our results
stratified by these specific subgroups do not necessarily match the
results provided by the CDC. According to the CDC, those 45
years of age or older and non-Hispanic white were less likely to be
undiagnosed among those with HIV and the slight increase for
men was much smaller than what we found. The CDC did not
evaluate history of testing [4,5]. We anticipate these results could
be due to a number of factors. First, these subgroups are generally
not suspected of being HIV-infected so they may not be offered
HIV testing as frequently. This hypothesis would apply mostly to
participants who were older and of non-Hispanic white race, with
demographic characteristics traditionally less associated with HIV
infection. Second, such persons may be more likely to refuse HIV
testing in the ED setting. This theory is corroborated by other
published USHER data that demonstrated those who were older
and non-Hispanic white were more likely to decline the test offer
[26]. Lastly, differences could also be attributed to the two
different estimation methods. We used USHER Trial data
supplemented with data from the MA/DPH Surveillance
Program, while the CDC used an extended back calculation
method [4,5].
There were a small number of undiagnosed cases found in the
USHER Trial, and our results could be due to uncertainty. Due to
the generally low prevalence of HIV, the estimated confidence
intervals are wide, especially for the estimation of the proportion of
HIV that is undiagnosed by specific subgroups. We suggest that
upper and lower confidence bounds should therefore be
considered to define plausible ranges for decision making, health
care planning and policy strategies. Because the goal was to
estimate prevalence, we did not report any p-values. Instead, we
used 95% confidence intervals as a measure of data uncertainty.
We also had a high rate of missing data for history of testing and
our assessment of risk behaviors. This was due to participants both
refusing to fill out the survey and not completing an already started
survey [27]. Analysis of our missing data patterns suggested that
missing data on history of testing were missing at random, but that
missing data on assessment of risk behaviors exhibited a slight
imbalance between those who were and were not tested. Since
such imbalance was relatively small, we do not anticipate it will
lead to appreciable bias in our risk-stratified prevalence estimates
[23].
This study has substantial implications for future study designs.
As HIV testing becomes more prevalent in all settings, the
proportion of HIV that is undiagnosed will continue to decrease.
Because of this decline, future studies that rely on the overall
prevalence (or diagnosed prevalence) of HIV in their specific
population as basis for power and sample size calculations will
greatly underestimate the number of subjects that need to be
recruited into their study. Also of note is that the CDC
recommends that routine screening programs should be per-
formed in settings that report an undiagnosed prevalence that is
greater than 0.1% [2]. This method of calculating the proportion
of HIV that is undiagnosed can be implemented by other EDs that
have implemented a screening program, provided they have the
data on newly diagnosed HIV and an estimate of the prevalence of
known HIV diagnoses for their ED. This can help inform ED
administrations on the feasibility of implementing an HIV
screening program.
A recent study by Lindsell et al. estimated the undiagnosed
prevalence of HIV to be 0.05% in an urban academic ED. In the
absence of data from their ED, they used zip code-specific case
rates of new diagnoses from clinics in the surrounding area of the
ED. They then multiplied these case rates by distribution of zip
codes within the ED and summed them to obtain estimate of
prevalence for the entire ED. The applicability of this method
depends greatly on the availability of data from multiple clinics
and treatment centers surrounding the ED. Even then, these
clinics may not reach the scope of patients that will attend that
particular ED [28].
We acknowledge that the prevalence estimates in our analyses
were derived from a single high-volume center. To use our data
to estimate undiagnosed prevalence in other settings, we suggest
that distributions of demographic characteristics and risk factors
in the population of interest should be combined with stratified
estimates, obtained from the current analysis. A weighted average
approach then will facilitate estimation of undiagnosed preva-
lence in the population of interest. Lastly, enrollment in the
USHER Trial did not cover overnight times and missed some
weekends. Thus, some HIV-infection may have been missed as
these represent the times that those at highest risk of HIV-
infection present to the ED.
Using data from an ED-based clinical trial, we found that
23.7% of all HIV infection is undiagnosed, a number similar to
that reported by the CDC. While there is considerable variability
in our estimates, our findings further note that the fraction of
undiagnosed HIV infection likely varies by demographic factors
and risk categories, including age, sex, race/ethnicity, history of
testing, sexual risk, and illicit drug use. These results suggest
further highlighting where targeted testing interventions may offer
the highest yield.
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